Drug Bioavailability: Estimation of Solubility, Permeability, Absorption and Bioavailability, Volume 40

0 avg rating
( 0 ratings by Goodreads )
 
9783527320516: Drug Bioavailability: Estimation of Solubility, Permeability, Absorption and Bioavailability, Volume 40

The gold standard for industrial research now completely revised in line with current trends in the field, with all contributions extensively updated or rewritten.
In 21 chapters readers can benefit from the key working knowledge of today's leading pharmaceutical companies, including Pfizer, AstraZeneca, and Roche. Drug developers from industry and academia present all the factors governing drug bioavailability, complete with practical examples and real-life data.
Part I focuses on in vitro and in vivo measurements of physicochemical properties, such as membrane permeability and ionization. Part II discusses solubility and gastrointestinal absorption, while the third part is devoted to metabolism and excretory mechanisms. The much revised and expanded part IV surveys current in silico approaches to predict drug properties needed to estimate the bioavailability of any new drug candidate. The final part shows how poor bioavailability may be improved by various approaches during the development process.
No other publication offers the same level of treatment on this crucial topic in modern drug development.

"synopsis" may belong to another edition of this title.

From the Back Cover:

In order to reach its intended site of action, the drug molecules in every pill that we swallow must first be absorbed, transported via the bloodstream and evade various mechanisms that eliminate drugs from the body. Those drug properties that determine, for example, its stability in the gut or its ease of uptake into the bloodstream, are therefore of central importance in drug development. In fact, many potentially useful drugs fail because of insufficient availability at the biological target site.
This second edition of the gold standard for industrial research is thoroughly revised in line with current trends in the field, with all contributions extensively updated or rewritten. No other publication offers the same level of treatment on this crucial topic.
In 22 chapters readers can benefit from the key working knowledge of today's leading pharmaceutical companies, including Pfizer, AstraZeneca, and Roche. Drug developers from industry and academia present all the factors governing drug bioavailability, complete with practical examples and real-life data.
Part I focuses on solubility and gastrointestinal absorption, while the second discusses in vitro and in vivo measurements of physicochemical properties, such as membrane permeability and solubility. Part III is devoted to metabolism and excretory mechanisms. The much revised and expanded Part IV surveys current in silico approaches to predict drug properties needed to estimate the bioavailability of any new drug candidate. The final part shows new drug development approaches as well as delivery strategies.
Indispensable for all those working in the pharmaceutical industry, pharmaceutical and medicinal chemists, and toxicologists.

About the Author:

Han van de Waterbeemd studied physical organic chemistry at the Technical University of Eindhoven, and gained his PhD in medicinal chemistry from the University of Leiden. After an academic career at the University of Lausanne with Bernard Testa, he worked for 20 years in the pharmaceutical industry for Roche, Pfizer and AstraZeneca. His research interests are in optimizing compound quality using measured and predicted physicochemical and DMPK properties. He has contributed to 145 research papers and book chapters, and (co-)edited 13 books, and was involved in organizing conferences and courses to promote medicinal chemistry, with a focus on physicochemistry and predictive approaches in drug design. Dr. van de Waterbeemd is on the editorial board of several journals and of Methods and Principles in Medicinal Chemistry.

Bernard Testa is Emeritus Professor of the University of Lausanne, having served there for 25 years as a full professor and head of medicinal chemistry. He has written 5 books and edited 33 others, and (co)-authored well over 450 research and review articles in the fields of drug design and drug metabolism. Between 1994 and 1998, he was the European Editor of Pharmaceutical Research, and is now a senior editor of Chemistry and Biodiversity, as well as serving on the editorial boards of several leading journals. Professor Testa holds honorary doctorates from the universities of Milan, Montpellier and Parma, and is a recipient of the Nauta Award on Pharmacochemistry given by the European Federation for Medicinal Chemistry.

"About this title" may belong to another edition of this title.

Buy New View Book
List Price: US$ 284.00
US$ 203.70

Convert Currency

Shipping: US$ 11.41
From United Kingdom to U.S.A.

Destination, Rates & Speeds

Add to Basket

Top Search Results from the AbeBooks Marketplace

1.

Han van de Waterbeemd
Published by Wiley VCH (2008)
ISBN 10: 3527320512 ISBN 13: 9783527320516
New Quantity Available: > 20
Seller
Books2Anywhere
(Fairford, GLOS, United Kingdom)
Rating
[?]

Book Description Wiley VCH, 2008. HRD. Book Condition: New. New Book. Shipped from UK in 4 to 14 days. Established seller since 2000. Bookseller Inventory # FW-9783527320516

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 203.70
Convert Currency

Add to Basket

Shipping: US$ 11.41
From United Kingdom to U.S.A.
Destination, Rates & Speeds

2.

Published by Wiley-VCH (2008)
ISBN 10: 3527320512 ISBN 13: 9783527320516
New Hardcover Quantity Available: 2
Seller
Murray Media
(North Miami Beach, FL, U.S.A.)
Rating
[?]

Book Description Wiley-VCH, 2008. Hardcover. Book Condition: New. Bookseller Inventory # P113527320512

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 218.97
Convert Currency

Add to Basket

Shipping: US$ 2.99
Within U.S.A.
Destination, Rates & Speeds

3.

Editor: Han van de Waterbeemd (AstraZeneca, Mereside, UK); Editor: Bernard Testa (University Hospital Lausanne, Switzerland); Series Editor: Raimund Mannhold (University of Düsseldorf, Germany); Series Editor: Hugo Kubinyi (University of Heidelberg, G
Published by John Wiley and Sons
ISBN 10: 3527320512 ISBN 13: 9783527320516
New Quantity Available: > 20
Seller
INDOO
(Avenel, NJ, U.S.A.)
Rating
[?]

Book Description John Wiley and Sons. Book Condition: New. Brand New. Bookseller Inventory # 3527320512

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 222.95
Convert Currency

Add to Basket

Shipping: US$ 3.50
Within U.S.A.
Destination, Rates & Speeds

4.

Han van de Waterbeemd
Published by Wiley 2008-10-15, Weinheim :|[Chichester (2008)
ISBN 10: 3527320512 ISBN 13: 9783527320516
New Hardcover Quantity Available: 1
Seller
Blackwell's
(Oxford, OX, United Kingdom)
Rating
[?]

Book Description Wiley 2008-10-15, Weinheim :|[Chichester, 2008. hardback. Book Condition: New. Bookseller Inventory # 9783527320516

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 236.98
Convert Currency

Add to Basket

Shipping: US$ 3.80
From United Kingdom to U.S.A.
Destination, Rates & Speeds

5.

Han Waterbeemd (Editor), Bernard Testa (Editor), Raimund Mannhold (Series Editor), Hugo Kubinyi (Series Editor), Gerd Folkers (Series Editor)
Published by Wiley-VCH (2008)
ISBN 10: 3527320512 ISBN 13: 9783527320516
New Hardcover Quantity Available: 1
Seller
Ergodebooks
(RICHMOND, TX, U.S.A.)
Rating
[?]

Book Description Wiley-VCH, 2008. Hardcover. Book Condition: New. 1. Bookseller Inventory # DADAX3527320512

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 269.56
Convert Currency

Add to Basket

Shipping: US$ 3.99
Within U.S.A.
Destination, Rates & Speeds

6.

Published by Wiley Vch Verlag Gmbh (2008)
ISBN 10: 3527320512 ISBN 13: 9783527320516
New Hardcover Quantity Available: 1
Seller
Rating
[?]

Book Description Wiley Vch Verlag Gmbh, 2008. Book Condition: New. Bookseller Inventory # L9783527320516

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 275.50
Convert Currency

Add to Basket

Shipping: US$ 2.22
From Germany to U.S.A.
Destination, Rates & Speeds

7.

Han Van De Waterbeemd
Published by Wiley VCH Verlag Gmbh Okt 2008 (2008)
ISBN 10: 3527320512 ISBN 13: 9783527320516
New Quantity Available: 1
Rating
[?]

Book Description Wiley VCH Verlag Gmbh Okt 2008, 2008. Buch. Book Condition: Neu. 248x178x49 mm. Neuware - 21 Kapitel, durchgesehen und aktualisiert: In diesem neu aufgelegten Standardwerk erklären Wirkstoffforscher aus dem akademischen und industriellen Umfeld alle Faktoren, die die Bioverfügbarkeit von Wirkstoffen beeinflussen. Teil 1 konzentriert sich auf die Messung physikalischer Eigenschaften (in vivo und in vitro), Teil 2 diskutiert Löslichkeit und gastrointestinale Absorption, Teil 3 widmet sich Fragen des Metabolismus und der Exkretion. Der besonders intensiv überarbeitete Teil 4 geht auf moderne Computermodelle zur Abschätzung der Bioverfügbarkeit potenzieller Wirksubstanzen ein. Der letzte Teil beschäftigt sich mit der Verbesserung der Bioverfügbarkeit durch maßgeschneiderte Syntheseprozesse. -- Mit Beiträgen von Wissenschaftlern führender Pharmaunternehmen wie Pfizer, AstraZeneca und Roche! The gold standard for industrial research now completely revised in line with current trends in the field, with all contributions extensively updated or rewritten. In 21 chapters readers can benefit from the key working knowledge of today s leading pharmaceutical companies, including Pfizer, AstraZeneca, and Roche. Drug developers from industry and academia present all the factors governing drug bioavailability, complete with practical examples and real-life data. Part I focuses on in vitro and in vivo measurements of physicochemical properties, such as membrane permeability and ionization. Part II discusses solubility and gastrointestinal absorption, while the third part is devoted to metabolism and excretory mechanisms. The much revised and expanded part IV surveys current in silico approaches to predict drug properties needed to estimate the bioavailability of any new drug candidate. The final part shows how poor bioavailability may be improved by various approaches during the development process. No other publication offers the same level of treatment on this crucial topic in modern drug development. 624 pp. Englisch. Bookseller Inventory # 9783527320516

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 275.50
Convert Currency

Add to Basket

Shipping: US$ 13.38
From Germany to U.S.A.
Destination, Rates & Speeds

8.

Han Van De Waterbeemd
Published by Wiley VCH Verlag Gmbh Okt 2008 (2008)
ISBN 10: 3527320512 ISBN 13: 9783527320516
New Quantity Available: 1
Seller
Agrios-Buch
(Bergisch Gladbach, Germany)
Rating
[?]

Book Description Wiley VCH Verlag Gmbh Okt 2008, 2008. Buch. Book Condition: Neu. 248x178x49 mm. Neuware - 21 Kapitel, durchgesehen und aktualisiert: In diesem neu aufgelegten Standardwerk erklären Wirkstoffforscher aus dem akademischen und industriellen Umfeld alle Faktoren, die die Bioverfügbarkeit von Wirkstoffen beeinflussen. Teil 1 konzentriert sich auf die Messung physikalischer Eigenschaften (in vivo und in vitro), Teil 2 diskutiert Löslichkeit und gastrointestinale Absorption, Teil 3 widmet sich Fragen des Metabolismus und der Exkretion. Der besonders intensiv überarbeitete Teil 4 geht auf moderne Computermodelle zur Abschätzung der Bioverfügbarkeit potenzieller Wirksubstanzen ein. Der letzte Teil beschäftigt sich mit der Verbesserung der Bioverfügbarkeit durch maßgeschneiderte Syntheseprozesse. -- Mit Beiträgen von Wissenschaftlern führender Pharmaunternehmen wie Pfizer, AstraZeneca und Roche! The gold standard for industrial research now completely revised in line with current trends in the field, with all contributions extensively updated or rewritten. In 21 chapters readers can benefit from the key working knowledge of today s leading pharmaceutical companies, including Pfizer, AstraZeneca, and Roche. Drug developers from industry and academia present all the factors governing drug bioavailability, complete with practical examples and real-life data. Part I focuses on in vitro and in vivo measurements of physicochemical properties, such as membrane permeability and ionization. Part II discusses solubility and gastrointestinal absorption, while the third part is devoted to metabolism and excretory mechanisms. The much revised and expanded part IV surveys current in silico approaches to predict drug properties needed to estimate the bioavailability of any new drug candidate. The final part shows how poor bioavailability may be improved by various approaches during the development process. No other publication offers the same level of treatment on this crucial topic in modern drug development. 624 pp. Englisch. Bookseller Inventory # 9783527320516

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 275.50
Convert Currency

Add to Basket

Shipping: US$ 19.10
From Germany to U.S.A.
Destination, Rates & Speeds

9.

Han Van De Waterbeemd
Published by Wiley VCH Verlag Gmbh Okt 2008 (2008)
ISBN 10: 3527320512 ISBN 13: 9783527320516
New Quantity Available: 1
Seller
Rheinberg-Buch
(Bergisch Gladbach, Germany)
Rating
[?]

Book Description Wiley VCH Verlag Gmbh Okt 2008, 2008. Buch. Book Condition: Neu. 248x178x49 mm. Neuware - 21 Kapitel, durchgesehen und aktualisiert: In diesem neu aufgelegten Standardwerk erklären Wirkstoffforscher aus dem akademischen und industriellen Umfeld alle Faktoren, die die Bioverfügbarkeit von Wirkstoffen beeinflussen. Teil 1 konzentriert sich auf die Messung physikalischer Eigenschaften (in vivo und in vitro), Teil 2 diskutiert Löslichkeit und gastrointestinale Absorption, Teil 3 widmet sich Fragen des Metabolismus und der Exkretion. Der besonders intensiv überarbeitete Teil 4 geht auf moderne Computermodelle zur Abschätzung der Bioverfügbarkeit potenzieller Wirksubstanzen ein. Der letzte Teil beschäftigt sich mit der Verbesserung der Bioverfügbarkeit durch maßgeschneiderte Syntheseprozesse. -- Mit Beiträgen von Wissenschaftlern führender Pharmaunternehmen wie Pfizer, AstraZeneca und Roche! The gold standard for industrial research now completely revised in line with current trends in the field, with all contributions extensively updated or rewritten. In 21 chapters readers can benefit from the key working knowledge of today s leading pharmaceutical companies, including Pfizer, AstraZeneca, and Roche. Drug developers from industry and academia present all the factors governing drug bioavailability, complete with practical examples and real-life data. Part I focuses on in vitro and in vivo measurements of physicochemical properties, such as membrane permeability and ionization. Part II discusses solubility and gastrointestinal absorption, while the third part is devoted to metabolism and excretory mechanisms. The much revised and expanded part IV surveys current in silico approaches to predict drug properties needed to estimate the bioavailability of any new drug candidate. The final part shows how poor bioavailability may be improved by various approaches during the development process. No other publication offers the same level of treatment on this crucial topic in modern drug development. 624 pp. Englisch. Bookseller Inventory # 9783527320516

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 275.50
Convert Currency

Add to Basket

Shipping: US$ 19.10
From Germany to U.S.A.
Destination, Rates & Speeds

10.

Published by Wiley-VCH (2008)
ISBN 10: 3527320512 ISBN 13: 9783527320516
New Hardcover Quantity Available: 1
Seller
Irish Booksellers
(Rumford, ME, U.S.A.)
Rating
[?]

Book Description Wiley-VCH, 2008. Hardcover. Book Condition: New. book. Bookseller Inventory # 3527320512

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 294.61
Convert Currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, Rates & Speeds

There are more copies of this book

View all search results for this book